Page last updated: 2024-10-15

3-hydroxykynurenine and Benign Neoplasms

3-hydroxykynurenine has been researched along with Benign Neoplasms in 2 studies

3-hydroxykynurenine: RN given refers to cpd without isomeric designation
3-hydroxykynurenine : A hydroxykynurenine that is kynurenine substituted by a hydroxy group at position 3.
hydroxykynurenine : A hydroxy-amino acid that is kynurenine substituted by a single hydroxy group at unspecified position. A "closed" class.

Research Excerpts

ExcerptRelevanceReference
"If bladder cancer is caused by agents present in the urine, as is widely believed, this mechanism may also protect against carcinogenesis."1.27Inactivation of antiadherence effect of bladder surface glycosaminoglycans as possible mechanism for carcinogenesis. ( Anderson, K; Kaufman, JE; Parsons, CL, 1987)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zuo, H1
Ueland, PM1
Eussen, SJ1
Tell, GS1
Vollset, SE1
Nygård, O1
Midttun, Ø1
Meyer, K1
Ulvik, A1
Kaufman, JE1
Anderson, K1
Parsons, CL1

Other Studies

2 other studies available for 3-hydroxykynurenine and Benign Neoplasms

ArticleYear
Markers of vitamin B6 status and metabolism as predictors of incident cancer: the Hordaland Health Study.
    International journal of cancer, 2015, Jun-15, Volume: 136, Issue:12

    Topics: Aged; Biomarkers; Female; Follow-Up Studies; Health Surveys; Humans; Incidence; Kynurenine; Male; Mi

2015
Inactivation of antiadherence effect of bladder surface glycosaminoglycans as possible mechanism for carcinogenesis.
    Urology, 1987, Volume: 30, Issue:3

    Topics: 3-Hydroxyanthranilic Acid; Animals; Bacterial Adhesion; Cyclamates; Glycosaminoglycans; Kynurenine;

1987